Focus groups can’t keep pace with the urgency of oncology. AI-driven simulations are changing the game—delivering insights on how oncologists respond to efficacy, safety, and competitive messaging.

JJ Mifsud

Beyond Focus Groups: AI Simulation for Smarter Oncology Insights

Pharma is evolving. Explore key shifts from Pharma USA 2025, from operationalizing precision to building trust, access, and human-centric engagement.

Steve Palmieri

Smarter, Simpler, More Human: What I saw at Pharma USA 2025

In 2025, digital mediation will shape our decision-making—from healthcare to daily life. How does this impact trust, connection, and choice? Read to find out.

Meredydd Hardie

Cultural Forces 2025: Mediated Existence

Jasmine Singh, EVP Medical Strategy, Klick Health, sits down with Dr. Scott Kopetz from MD Anderson to talk about minimal residual disease and why cancer that doesn’t show up on a scan can still be a threat. They get into circulating tumor DNA, early intervention, and what’s next in colorectal cancer research.

Scott Kopetz

Jasmine Singh

Charting the Future of Colorectal Cancer

Klick’s 5P framework empowers medical affairs teams to enhance DOL engagement using strategic profiling, planning, partnering, and social media to drive lasting medical impact.

Robert Groebel III

From Strategy to Impact: Amplify Scientific Communication

See how pharma brands can use AI, scenario planning, and strategic flexibility to anticipate market shifts, adapt to uncertainty, and drive long-term success.

Brian Kaiser

Exploring Optionality and Brand Resilience

The FDA is scrutinizing celebrity pharma ads. Learn how Klick ensures compliance by balancing authenticity, risk communication, and efficacy claims in influencer marketing.

Cassandra Carroll

Bahar Ameri

Compliance in Influencer Marketing: Klick's Approach to FDA Standards

This overview clarifies DOL engagement best practices, ensuring collaborations are transparent, credible, and anchored in long-term trust.

Tim Mitchell

Clarity Amid Complexity: Demystifying Key Regulatory Requirements for DOL Collaborations

AI is transforming pharma, but adoption challenges remain. From scaling AI literacy to balancing innovation with compliance, discover key insights from the “Age of AI, Europe.”

Entdecken

Stay Informed with the Klick Wire